Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What do you think MAGA, we may have to drop to 20 RSI before we get a good technical bounce here. Don't see any other way you attract any buyers barring a major catalyst/milestone.
Yeah MAGA, unfortunately there has just been no interest here for a long time. Even at these levels your not seeing any sustained big buys coming in like we did in Jan when we hit .06. Until we hit a real catalyst/milestone, unfortunately we will be at the mercy of how low they want to take us. And it's really pretty easy for them to do with relatively low ASK walls.
What really is crazy MAGA is that this is happening with virtually zero dilution in the last 2 yrs, the 32.5 million were added to the restricted so couldn't be sold. Most tickers during that run have diluted hundreds of millions and even billions of shares since then. I can only imagine if we had been diluting this whole time where we would be at now.
Different day same pattern here Maga. Until some real vol/support kicks in, or a major catalyst hits, this is where we are stuck. You have to be behind at least 2 full quarters before you go to the Expert Market, which I don't think there is any chance of that happening. So we have a long time to worry about that.
Yep, same playbook with PAUL now in control while others put up big ASK walls right behind him. It was STXG for awhile, which leads me to believe this could be a group of investors using the low vol and lack of buying interest here to control the price in this channel. Obviously any sorta news now and this would end very quickly, but until then the pattern will continue.
I agree MAGA, and its quite surprising we are actually holding these levels with us not having a single green buying day of over 15 million shares I believe since Jan. Down on the weekly chart 15 out of 18 weeks, delayed financials and IPF Immune release, no PR in almost 2 months, and dead silence from Dr Chandra in a month. So unless you are a long and have some DD about the company and what is happening in background, there really has been zero reason for retail investors to jump on board at the moment.
We haven't had a PR in almost 2 months now, Dr Chandra hasn't Tweeted in a month, and the Hicks interview had to be cancelled because they are waiting on NDA's to clear. We should be getting that catalyst that could send this much higher in the next 4-5 weeks. But your right, until then PAUL & STXG will do there thing as we remain in "Groundhog Day" until then.....lol
Yeah not sure 2b we would get any type of answer to that question. Normally this type of behavior by a market maker is dilution, but we haven't added any shares to OS except those 30 million or so recently. We know Charles said that he negotiated a 2 yr freeze on any new convertible debt being added, which expires sometime in October. ASCM is another known shorter or diluting market maker, and they seem to always show up when there is a major increase in vol that suddenly shows up in any OTC ticker. But I'm not really familiar with SXTG other than here in ENZC.
Yeah I agree, has to be quite a bit going on behind the scenes that can't be shared at this time.
Ok I thought you were strictly talking about the ASK. It seems they are more careful down here in the mid to upper.05's, where the big demand sits and waits, so they keep us this exact same trading range.
I completely agree MAGA, if you go back to April of 2021, after the Emerging Growth Conference, Charles laid out a ton of stuff with timelines, and I know things get delayed and they don't want to give any timelines, but you would think there would be a ton of stuff that they could PR. In the short run, my eyes are focused on toxicity study results, because that will unlock the next steps for ITV-1 in Europe and Africa. Also, what about our animal Mabs, and getting them to market by the 4Q 2022, which obviously would be a long shot right now, but they haven't even announced our partner. Back in November I believe, they were actively looking at multiple proposals, so we could here something anytime now.
Oh no doubt. I've seen days where the ASK was hit to the tune of millions and SXTG didn't budge off their 10k ASK.
Ok gotcha. Unfortunately liquidity has been really drying up in the OTC, the only big $$$ vol days we've had over the last 6 months has been to the downside by a lot, like 3 to 1 decliners to advancers. Can't remember a high vol day in the OTC and we had 2 or 3 to 1 advancers to decliners. We are going to need a major catalyst/milestone to hit to change the narrative here. IPF can/will be a good revenue generating product, but that has been advertised basically since January. We need something new to catch people off guard, and get this vol higher and out of the doldrums. Chandra has been fairly quiet as of late, maybe we are close.
Hey MAGA, I'm wondering if SXTG has anything to do with those shares that went from restricted to unrestricted. I've obviously noticed SXTG, but I can't remember them being this aggressive like they are now. I wonder if they appeared around the same time those shares became unrestricted, and somebody has been dumping them.
Yep, exactly MAGA. We need the toxicology study results in order to move forward on 2 big fronts imo. ITV-1 trials in Europe and the sale in Africa. Also, haven't heard really much where they are at with the Samsung Biologics partnership, since they announced it 7 months ago. I think Samsung has produced the Mabs, but past that not a lot of info right now.
Whoever is behind STXG, has millions of shares to dump whenever they start getting aggressive on the ASK with their seemingly unlimited 10k ASK. Seen this time and time again as we basically stay in this same channel, until we get major news/catalyst to get more vol/money to invest and hold.
Yeah I agree MAGA, a little different circumstances and environment. Right now we have probably one of the worst macro environments you could possibly have, on top of that, ENZC just happens to be in one of the most beaten down sectors, a R & D biotech that has zero revs. Fear index at all-time high, along with inflation percentages that haven't been seen in almost 40 yrs.
No stocks are trading on hype anymore, this is a vastly different environment, so unless there is a massive catalyst/news, I think we will stay that way until the dam breaks sorta speak. IPF is great and the revs from that could be substantial, but we have known about it for almost 6 months now and it will obviously take awhile to start to see those revs.
The last major news/catalyst was us landing Samsung Biologics, which was out of the blue and caught everyone off guard. I can't stress how huge that really is, and since we haven't heard anything since the Oct announcement, the market/people tend to forget or they are waiting for more news from that partnership. Our Mabs is why almost everyone that wasn't here pre-merger is invested, or at least that's what I'm thinking. But I love the strategy actually of going after the low hanging fruit first to get a revenue stream going, before going through the trials for our monoclonal antibodies, which will cost millions to do.
Last time we saw this big of a shakedown was during the Emerging Growth Conference. That shakedown was coordinated almost immediately with the start of the interview with Charles. This happened a day later and after the podcast that Dr Chandra was on. Silver lining is we ran from a low of .086 to almost .32 afterwards, so big things are coming soon imo.
Someone dumping all their shares with NITE at .06, been hit a million times already
Yep no worries, it's a little frustrating time for many here.
Ok your right the Annual Report was filed and subsequent extension was for the financials, so basically enough to keep us pink current with the guidelines.
I never said they were and I was referring to MAGA asking about the 10/K, which was filed on time on 3/31, and the extension and filing yesterday was for the financials. Has nothing to do with being audited.
Correct, you have 120 days I believe to file an attorney letter, so that would be the end of April. I don't think these are audited finacials, when that process is over I think it will not only be announced, but stated in the disclosure section.
The K was filed on 3/31, and then the 15 day extension was for the financials, which were filed yesterday.
Yep for sure......The hiring of Tom was obviously a mistake, and I think it was a rushed hire and was given very little thought imo. I know they were getting hammered at that time with tons of calls/emails daily, and I just think they wanted that burden/weight removed from them. Maybe they paid for a year of his service up front, which will be ending in May, but it definitely wasn't a good look as far as credibility that's for sure. But we are dealing with a newly formed OTC Pink Co, so mistakes and delays are definitely going to happen, albeit very frustrating for us investors.
Good summary Jack and I pretty much agree with everything you said. Speculative stocks such as ENZC and the entire OTC are going to get hit the hardest in this environment. You have to be willing to ride it out and handle the extreme turbulence that comes with it, and like you said it could be a year or longer before things start to turn favorable again. Also, ENZC is in it's infancy still, and will take years to eventually cross the finish line, especially for Clone 3, which for me is what everyone is waiting to see.
Here is the reason why ENZC along with a host of other R&D biotech stocks have been hammered as of late. Evaluations of these clinical or pre-clinical stage stocks that have no revenue streams, is often very turbulent and hard to put a proper valuation on. Here is an excerpt from an article written last month to give you an example.......
I think the main reason why the clinical-stage biotech stocks got hit especially hard is that they trade at prices that are really totally at the whim of investors. Established biotechs with products on the market generating sales, those kind of companies, investors can look at them, they can look at their business, they can see how the sales are growing for their existing products, they can look at their pipelines, and they can come up with a, I guess, more reasonable guess of their valuation. But a clinical-stage biotech stock is just a lot harder to do that with. It's all about what do you think their potential is, and when investors are in a sour mindset, which is what happened last week, these stocks are going to get hammered, and that's exactly what we saw.
Orelli: The other issue is that they're going to be based on future earnings, and then discounted for risk-adjusted discount, and so that means when the price of interest rates goes up, now you're talking about risk-free or less risk. You get more for those when the interest rates go up, and therefore, you need to account for that in the valuation, and so that drives down valuations.
Speights: Exactly. That impacts all stocks. But it especially hits the more speculative stocks, clinical-stage biotech stocks just are more speculative by nature.
So basically we have the auditing of 2 separate companies, and the error wasn't discovered until June 2021, which means how long did it take from there for Charles to provide all the Bioclonetics financials to Malone & Bailey, and how busy/backed up were Malone & Bailey at that time??
I mean let's face some facts here, ENZC prior to the merger was a complete mess, coupled with many skeletons in the closet at best, hence why the share price stayed in the trip zeros. Just to begin to start to clean up this mess has taken a herculean effort imo.
Any reason for the Yield sign? 1Q not due til April 15, so I can't figure out the reason.
The financials here are a disaster and heading in the wrong direction. 1Q revs were over 500k and the OE was 2.6 million. Now, 2 quarters later, the OE has nearly doubled to 5.1 million and revs are just slightly over 300k. On top of the OE exponentially growing, the cost to service the debt was 2 million last Q. It's just impossible to see how they move forward this year, with the amount of money that's going to be necessary, and revs that haven't even come close to the 1Q, although now they have double the employees and around 7 salespeople. The math simply doesn't add up, and people have been hoping/praying for these large orders which never happen.
I stop by here every now and then, and I still see some familiar faces, but can't understand for the life of me what is the lure with this stock? Going back to 2014, this is easily one of the absolute worst performing stocks in the Nasdaq, with numerous rs and another one the way. Like other than a dead cat bounce back in 2020 when the pandemic hit, it's been nothing but straight downhill and a diluting machine. I just can't believe they are still not only on the Nasdaq, but have the doors open at all.
Yeah MAGA I've been here watching L2 a long time like you have, and this definitely seems very coordinated. Look at GTSM premarket on L2, raising the ASK initially at .0801 and then constantly lowering it to below yesterday's close at .077. Huge ASK walls continue to pop up all day everyday now, and like you said, the ASK does get hit they immediately drop it. I agree with you that the only way out is vol at this pt, which we are completely lacking here. So it's very easy to do when there is low vol/interest to begin with. Hopefully the worst of this will be behind us after next week, but there has been no let up insight.
CDEL back on the ASK only pre-market @ .109, so looking for the same play here as they let it rise right off the bat and then pull it down with their ASK walls. CDEL has been very very aggressive as of late, meaning they don't want this to run at the moment for some reason. Until we get some vol back here, 30+ million, we are unfortunately at the mercy of CDEL & Co. Trends are made to be broken but over the past year I've seen us go green only once I believe when CDEL showed up premarket on the ASK only.
Need to buck the trend here today with CDEL being on the ASK only pre-market, I think we have maybe closed green one day when that occurs. Would love to see the vol we had from Friday to continue today, but we'll see.
Most definitely. I mean it's going to be a bumpy ride with many highs/lows and sp swings until we continue to prove the tech through clinical trials. Very early stages and excited to see this through.
No, I definitely agree with you.
No believe me I understand that, and that will also be the ideal route for Clone 3, but CC did say they are willing to go it alone if they have to.
I agree Jack, but I believe CC thought that ITV-1 was basically low hanging fruit, and the quickest way to get a drug to market and revenue, which will obviously be needed in some form for Clone 3 trials. But your right, the big enchilada is Clone 3, and if you are going to see it through to the end, it will take probably 2-3 years.
You could be right MAGA, and I could have sworn they were loading in the .11's, but I definitely believe they were in the .12's for sure last time. So yeah to see them on the ASK, sometimes with large amounts, could have been to get the sp down to where they could load again. But when they were loading, it was always with a 5k BID, and they were never on the ASK. So whatever games they may have been playing, it seems there back to their accumulation mode for the time being. Also of note, is they never chase or hit the ASK. They are very patient and let the buyers come to them. They will move their BID higher if other mm come in and raise the BID above them, but like today they just sat at .1150 all afternoon basically.
Hey MAGA, INTL was definitely back today and basically brought us up to our closing price of .1166. The key indicator with them of course is there 5k BID only, and not on the ASK. They basically bowed out over a month ago and have really been a non factor. They had a BID at .1150 for the last hour that never budged. Hopefully they'll be back at it bright and early tomorrow.